DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18593
| null |
Recombinant neuroglobin
| null | null |
recombinant neuroglobin (rNgb) containing mutations H64Q/C46G/C55S/C120S
| null |
DB18594
| null |
NGN-401
| null | null |
Recombinant serotype 9 adeno-associated virus (AAV) encoding an intron encoding a miRNA generating sequence, complementary miRNA binding sites and a full-length human methyl cytosine binding protein 2 (MECP2)
| null |
DB18595
| null |
FCR001
| null | null | null | null |
DB18596
| null |
M1-c6v1
| null | null | null | null |
DB18597
| null |
Timolumab
|
1073538-99-4
|
UJO03RO3K6
|
recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1)
| null |
DB18598
| null |
INH-A21
| null |
9LKK68BOP0
| null | null |
DB18599
| null |
TSHA-102
| null | null | null | null |
DB18600
| null |
DM-1157
|
1239953-66-2
|
6X58GJ0RMS
|
4-quinolinamine, 7-chloro-n-(3-(4-((di-2-pyridinylmethyl)amino)-1-piperidinyl)propyl)-
|
QRCZXFIANKOFOR-UHFFFAOYSA-N
|
DB18601
| null |
Alpha-1-acid glycoprotein
| null |
31V857ZRPY
|
.ALPHA.-1-ACID GLYCOPROTEIN | AGP 1 | ALPHA-1-ACID GLYCOPROTEIN 1 | ALPHA-1-ACID GLYCOPROTEIN-1 | ORM1 | OROSOMUCOID-1
| null |
DB18602
| null |
Perenostobart
|
2643331-31-9
|
O84ZK2F68E
|
Immunoglobulin G4 [229-proline], anti-(human ectonucleoside triphosphate diphosphohydrolase 1) (human monoclonal SRF617 γ4-chain), disulfide with human monoclonal SRF617 κ-chain, dimer | immunoglobulin G4-kappa, anti-[ENTPD1(ectonucleoside triphosphate diphosphohydrolase 1, NTPDase-1, ATPDase, SPG64, CD39)], Homo sapiens monoclonal antibody
| null |
DB18603
| null |
APPD
|
2364414-26-4
|
YG9BKQ6J2Z
|
AMINOURIDYL PHENOXYPIPERIDINBENZYL BUTAMIDE | D-GLYCERO-.ALPHA.-L-TALO-HEPTOFURANURONAMIDE, 5-O-(5-AMINO-5-DEOXY-.BETA.-D-RIBOFURANOSYL)-1,6-DIDEOXY-1-(3,4-DIHYDRO-2,4-DIOXO-1(2H)-PYRIMIDINYL)-6-((4-OXO-4-(((4-(4-(4-(TRIFLUOROMETHOXY)PHENOXY)-1-PIPERIDINYL)PHENYL)METHYL)AMINO)BUTYL)AMINO)-
|
XXRKRPJUCVNNCH-AMFJOBICSA-N
|
DB18604
| null |
TPX-4589
| null | null |
Antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE
| null |
DB18605
| null |
ECT204
| null | null | null | null |
DB18606
| null |
ISTH0036
| null | null | null | null |
DB18607
| null |
Sulfobutylether-beta-cyclodextrin
|
182410-00-0
| null | null | null |
DB18608
| null |
Sapablursen
|
2273007-95-5
|
DXS4HJC32N
|
Ionis tmprss6-lrx
| null |
DB18609
| null |
VCA-894A
| null | null | null | null |
DB18610
| null |
P-42 peptide
| null | null | null | null |
DB18611
| null |
PAS-004
| null | null | null | null |
DB18612
| null |
IDUA-RTB
| null | null |
IDUA:RTB | RTB-IDUA | RTB:IDUA
| null |
DB18613
| null |
PRG-A01
| null | null |
Amisodin
| null |
DB18614
| null |
ST266
| null | null | null | null |
DB18615
| null |
VGB-R04
| null | null | null | null |
DB18616
| null |
AAV9/MFSD8
| null | null |
An adeno-associated virus serotype 9 (AAV9) vector with engineered transgene encoding the human CLN7/MFSD8 gene for expression of active human major facilitator superfamily domain containing 8
| null |
DB18617
| null |
WU-CART-007
| null | null |
an allogeneic, fratricide-resistant genetically modified T cell transduced with a 2nd generation 4-1BB-CD3z chimeric antigen receptor targeting human CD7
| null |
DB18618
| null |
Givastomig
| null | null |
an anti-Claudin 18.2 and 4.1BB Bispecific Antibody | TJ-CD4B/ABL111
| null |
DB18619
| null |
CMG901
| null | null |
an anti-Claudin 18.2 monoclonal antibody conjugated with MMAE payload
| null |
DB18620
| null |
AOC 1001
|
2653183-66-3
|
9Q5NSR8WV9
|
Delpacibart | Immunoglobulin G1 [233-alanine,234-alanine,327-arginine,de-446-lysine], anti-(human type 1 transferrin receptor) (human-Mus musculus clone AV05 γ1-chain), disulfide with human-Mus musculus clone AV05 κ-chain, dimer
| null |
DB18621
| null |
AOC-1020
| null | null |
An antibody oligonucleotide conjugate, comprised of a human transferrin receptor 1 targeting, effector function null, humanized IgG1 antibody, a MCC maleimide linker, and a double-stranded siRNA oligonucleotide targeting DUX4
| null |
DB18622
| null |
ABBV-011
| null | null |
an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin
| null |
DB18623
| null |
Prizloncabtagene autoleucel
| null | null |
an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR | autologous T lymphocytes obtained from peripheral blood lymphocytes by leukapheresis, transduced with a self-inactivating, non-replicating lentiviral vector, encoding a bispecific chimeric antigen receptor targeting CD19 and CD20 | Prizloncabtagene autoleucel
| null |
DB18624
| null |
VOR33
| null | null |
allogeneic CRISPR/Cas9 genome-edited hematopoietic stem and progenitor cell (HSPC) therapy product lacking the CD33 protein
| null |
DB18625
| null |
CTX120
| null | null |
allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting B-cell maturation antigen
| null |
DB18626
| null |
CTX110
| null | null |
allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting CD19 antigen
| null |
DB18627
| null |
CTX130
| null | null |
Allogeneic CRISPR/Cas9-mediated genetically modified CAR T cells targeting CD70 antigen
| null |
DB18628
| null |
TTX-MC138
| null | null |
Dextran-coated, nanoparticle-conjugated stabilized synthetic antisense oligonucleotide targeting miR-10b
| null |
DB18629
| null |
AB-201
| null | null |
Ex vivo expanded allogeneic cord blood-derived NK cells that have been genetically modified to express a HER2-directed CAR and secrete IL-15
| null |
DB18630
| null |
Allogeneic natural killer cells
| null | null |
Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells
| null |
DB18631
| null |
AVR-RD-05
| null | null |
Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
| null |
DB18632
| null |
1-(3-fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydro-1H-isoindo-1-4-yl)-phenyl)-3-(3-trifluoromethyl-phenyl)-urea
|
1370466-81-1
|
7W3FGR71NN
|
Urea, n-(4-(2,3-dihydro-7-(5-methyl-1h-imidazol-2-yl)-1-oxo-1h-isoindol-4-yl)-3-fluorophenyl)-n'-(3-(trifluoromethyl)phenyl)
|
BOLRZWTVMUHQQU-UHFFFAOYSA-N
|
DB18633
| null |
Uttroside B
|
88048-09-3
|
QK6VN86E3T
|
.beta.-d-galactopyranoside, (3.beta.,5.alpha.,22.alpha.,25r)-26-(.beta.-d-glucopyranosyloxy)-22-hydroxyfurostan-3-yl o-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-xylopyranosyl-(1->3))-o-.beta.-d-glucopyranosyl-(1->4)-
|
FJLUJBDSFBGOPL-YOKUEUOXSA-N
|
DB18634
| null |
Vasoactive intestinal peptide
|
37221-79-7
|
6J2WVD66KR
|
His-ser-asp-ala-val-phe-thr-asp-asn-tyr-thr-arg-leu-arg-lys-gln-met-ala-val-lys-lys-tyr-leu-asn-ser-ile-leu-asn | Vasoactive intestinal peptide (human) | Vasoactive intestinal polypeptide | VIP
|
VBUWHHLIZKOSMS-RIWXPGAOSA-N
|
DB18635
| null |
Microbial collagenase
| null |
FY14NZH2SF
|
VIBRIO ALGINOLYTICUS COLLAGENASE
| null |
DB18636
| null |
SLN500
| null | null | null | null |
DB18637
| null |
CYNK-101
| null | null |
allogeneic human placental hematopoietic stem cell derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP)
| null |
DB18638
| null |
CLZ-2002
| null | null |
allogeneic mesenchymal stem cells derived neuronal regeneration promoting cells
| null |
DB18639
| null |
MT-401
| null |
L4D9X59F34
| null | null |
DB18640
| null |
ALLO-715
| null |
Q137JC2CLV
|
Allogenic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen (BCMA)
| null |
DB18641
| null |
ALLO-605
| null | null | null | null |
DB18642
| null |
OTL-102
| null | null |
Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene
| null |
DB18643
| null |
OTL-203
| null | null |
Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex-vivo using a lentiviral vector encoding alpha-L-iduronidase gene
| null |
DB18644
| null |
AVR-RD-04
| null | null |
autologous CD34+ enriched cells transduced with a lentiviral vector containing RNA resulting in codon-optimized cDNA encoding for functional human cystinosin
| null |
DB18645
| null |
EDIT-301
| null | null |
Autologous CD34+ hematopoietic stem and progenitor cells edited by CRISPR/CAS12a at the HBG1 and HBG2 promoters | autologous CD34+ hematopoietic stem and progenitor cells edited by CRISPR/Cas12a ribonucleoprotein (RNP) at the HBG1 and HBG2 promoters
| null |
DB18646
| null |
SLN124
| null | null | null | null |
DB18647
| null |
Allogenic fetal mesenchymal stem cells
| null | null | null | null |
DB18648
| null |
MaaT013
| null | null | null | null |
DB18649
| null |
Prosetin
| null | null | null | null |
DB18650
| null |
ATIR101
| null | null | null | null |
DB18651
| null |
Allogeneic human pancreatic islets of Langerhans
| null | null | null | null |
DB18652
| null |
TUM012
| null | null | null | null |
DB18653
| null |
ssCART-19 cells
| null | null |
autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
| null |
DB18654
| null |
Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells
| null | null |
Autologous Chimeric Antigen Receptor (CAR) Modified Recombinant T Cells Targeting EGFRvIII | EGFRvIII CAR-T
| null |
DB18655
| null |
Autologous CD4+CD25hiFoxP3+regulatory T cells
| null | null | null | null |
DB18656
| null |
HUB-101
| null | null |
Adeno-associated viral 2/5 (AAV2/5) vector expressing the human KCNJ13 gene
| null |
DB18657
| null |
PARPI F-18
|
1883580-48-0
|
FT8GT4M7UG
|
(18F)PARPI | 1(2h)-phthalazinone, 4-((4-fluoro-3-((4-(4-(fluoro-18f)benzoyl)-1-piperazinyl)carbonyl)phenyl)methyl)-
|
LTZZZXXIKHHTMO-GLOFJIOZSA-N
|
DB18658
| null |
MBX-2109
| null | null | null | null |
DB18659
| null |
Avoplacel
| null |
79NT7I8J0C
|
Avoplacel
| null |
DB18660
| null |
Ex vivo expanded autologous human corneal epithelial cells containing stem cells
| null | null | null | null |
DB18661
| null |
Influenza A virus A/Norway/31694/2022 (H1N1) live (attenuated) antigen
| null | null | null | null |
DB18662
| null |
Rugonersen
|
2591587-57-2
|
F77TA4U3SP
|
Rugonersen | UBE3A antisense oligonucleotide with locked nucleic acids
| null |
DB18663
| null |
AMP-201
| null | null |
Adeno Associated Virus Serotype 8 Encoding the Collagen Q Gene
| null |
DB18664
| null |
BGT-DTDS
| null | null |
Adeno-associated viral vector serotype 2 containing the human SLC6A3 gene
| null |
DB18665
| null |
Psoralen
|
66-97-7
|
KTZ7ZCN2EX
|
6-hydroxy-5-benzofuranacrylic acid .delta.-lactone | Ficusin
|
ZCCUUQDIBDJBTK-UHFFFAOYSA-N
|
DB18666
| null |
HG004
| null | null |
Adeno-associated viral vector serotype 9 (AAV9) containing human RPE65 gene
| null |
DB18667
| null |
BG1805
| null | null | null | null |
DB18668
| null |
BBT-877
| null | null | null | null |
DB18669
| null |
RGG0853
| null | null |
E1A gene therapy | HER-2/neu inhibitor | RGG0853, E1A lipid complex | tgDCC-E1A gene therapy
| null |
DB18670
| null |
SM-1997
| null | null |
Solution of protein-free hemodialysate of calf blood
| null |
DB18671
| null |
NDX-3315
| null | null |
technetium-99m radiolabeled heparin
| null |
DB18672
| null |
Suratadenoturev
|
1268642-13-2
|
FV0JG1SX76
|
A recombinant replication-competent adenovirus type 5 (Ad-5) in which the E1 gene, including its normal transcriptional regulatory element, has been deleted and replaced by an expression cassette containing an hTERT (human telomerase reverse transcriptas | A replication-competent adenovirus type 5 in which the E1A and E1B genes are under the control of a human telomerase reverse transcriptase (hTERT) and IRES, respectively. | DNA (recombinant human telomerase-specific replication-competent oncolytic adenovirus 5 vector OBP-301) | Telomelysin | Telomerase Specific Replication-competent Oncolytic Adenovirus
| null |
DB18673
| null |
XEN-D0501
| null | null |
Tetrahydronaphthyl urea based selective TRPV1 antagonist
| null |
DB18674
| null |
Acimtamig
|
2738880-26-5
|
ND470TT8Y3
|
AFM13 (ANTI CD30 X ANTI CD16) | ANTI-CD30/CD16A MONOCLONAL ANTIBODY AFM13 | Immunoglobulin, anti-(human FcγRIIIa receptor) (human heavy chain V-D-J region) fusion protein with peptide linker (GGS)3 fusion protein with immunoglobulin anti-(human CD30 antigen) (human-Mus musculus single-chain Fv fragment VL-(GGS)3-VH) fusion prot | tetravalent bispecific chimeric anti-human CD30 x anti-human CD16A recombinant antibody construct
| null |
DB18675
| null |
Ozekibart
|
2539847-03-3
|
R0GA5221D4
|
Immunoglobulin, anti-(human death receptor 5) (human-Lama glama clone IF5 single-domain VHH fragment) fusion protein with peptide linker (GGS)2 fusion protein with immunoglobulin anti-(human death receptor 5) (human-Lama glama clone IF5 single-domain VHH | Tetravalent recombinant humanized IgG1 agonist antibody targeting the human TRAIL death receptor 5 (DR5).
| null |
DB18676
| null |
Palopegteriparatide
|
2222514-07-8
|
G2N64C3385
|
Human parathyroid hormone (PTH) synthetic peptide fragment (1-34), conjugated at the N-terminal amino group via a cleavable linker to O-methylpolyethylene glycol (2 x 20 kDa mPEG); 2-methylalanyl-(1-34)-peptide of parathyroid hormone (Homo sapiens parath | Mpeg 40000-teriparatide | Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-L-seryl-L-valyl-L-seryl-L-α-glutamyl-L-isole | Transcon parathyroid hormone (1-34) | TransCon PTH | Transcon pth (1-34)
| null |
DB18677
| null |
Ulefnersen
|
2589926-25-8
|
TND56EA1LE
| null | null |
DB18678
| null |
DNL343
|
2278265-85-1
|
FYL3Y9D7SK
| null | null |
DB18679
| null |
Autologous adipose-derived stromal vascular fraction cells
| null | null |
Autologous adipose-derived stromal vascular fraction cells | Autologous stromal vascular cell fraction from adipose tissue | Autologous stromal vascular fraction from adipose tissue
| null |
DB18680
| null |
Lovotibeglogene autotemcel
| null |
2C6A9NH2Z8
|
Lovo-cel
| null |
DB18681
| null |
Autologous CD34+ hematopoietic stem and progenitor cells expressing adenosine deaminase
| null | null | null | null |
DB18682
| null |
NVL-655
| null | null |
an orally bioavailable ALK inhibitor (a macrocyclic compound containing nitrogen heterocycles)
| null |
DB18683
| null |
APG-157
| null | null | null | null |
DB18684
| null |
Recombinant human insulin-like growth factor 1
| null | null | null | null |
DB18685
| null |
Whey
| null |
8617Z5FMF6
|
Allergenic Extract- Whey, Cow's Milk | Bovine Milk Plasma | Bovine Whey | Cow Milk Whey | Food - Dairy Products, Whey, Cow's Milk | Milk Basic Protein | Proteins, Whey | Ultracur Component Whey Protein | Whey Dried | Whey Protein | Whey Protein Component Of Ultracur | Whey Protein Concentrate
| null |
DB18686
| null |
MBP134
| null | null |
Two immunoglobulin subclass 1 (IgG1) human monoclonal antibodies that target the Sudan ebolavirus glycoprotein
| null |
DB18687
| null |
EDIT-101
| null | null |
a recombinant adeno-associated virus pseudotyped with serotype 5 viral capsid encoding CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats associated protein 9) gene editing constructs
| null |
DB18688
| null |
Cellspan Esophageal Implant
| null | null | null | null |
DB18689
| null |
GDP-L-fucose
|
15839-70-0
|
SM108QK2IH
|
Gdp-.beta.-l-fucose | Gdp-fucose | Guanosine 5'-(trihydrogen pyrophosphate), mono(6-deoxy-l-galactopyranosyl) ester | Guanosine 5'-diphospho-.beta.-l-fucose | Guanosine 5'-pyrophosphate, .beta.-l-fucopyranosyl ester | Guanosine pyrophosphate, l-fucosyl ester
|
LQEBEXMHBLQMDB-JGQUBWHWSA-N
|
DB18690
| null |
TZ-101
| null |
K2X1EE8C73
| null | null |
DB18691
| null |
Rovaleucel
| null |
TL8FKX4ISW
| null | null |
DB18692
| null |
inBreath airway transplant system
| null | null | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.